FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2140700178> ?p ?o ?g. }

• W2140700178 endingPage "735" @default.
• W2140700178 startingPage "725" @default.
• W2140700178 abstract "Anaplastic thyroid cancer (ATC) has no effective treatment, resulting in a high rate of mortality. We established cell lines from a primary ATC and its lymph node metastasis, and investigated the molecular factors and genomic changes associated with tumor growth. The aim of the study was to understand the molecular and genomic changes of highly aggressive ATC and its clonal evolution to develop rational therapies. We established unique cell lines from primary (OGK-P) and metastatic (OGK-M) ATC specimen, as well as primagraft from the metastatic ATC, which was serially xeno-transplanted for more than 1 year in NOD scid gamma mice were established. These cell lines and primagraft were used as tools to examine gene expression, copy number changes, and somatic mutations using RNA array, SNP Chip, and whole exome sequencing. Mice carrying sc (OGK-P and OGK-M) tumors developed splenomegaly and neutrophilia with high expression of cytokines including CSF1, CSF2, CSF3, IL-1β, and IL-6. Levels of HIF-1α and its targeted genes were also elevated in these tumors. The treatment of tumor carrying mice with Bevacizumab effectively decreased tumor growth, macrophage infiltration, and peripheral WBCs. SNP chip analysis showed homozygous deletion of exons 3–22 of the PARD3 gene in the cells. Forced expression of PARD3 decreased cell proliferation, motility, and invasiveness, restores cell-cell contacts and enhanced cell adhesion. Next generation exome sequencing identified the somatic changes present in the primary, metastatic, and primagraft tumors demonstrating evolution of the mutational signature over the year of passage in vivo. To our knowledge, we established the first paired human primary and metastatic ATC cell lines offering unique possibilities for comparative functional investigations in vitro and in vivo. Our exome sequencing also identified novel mutations, as well as clonal evolution in both the metastasis and primagraft." @default.
• W2140700178 created "2016-06-24" @default.
• W2140700178 creator A5000444064 @default.
• W2140700178 creator A5007939153 @default.
• W2140700178 creator A5008473414 @default.
• W2140700178 creator A5015705148 @default.
• W2140700178 creator A5016350669 @default.
• W2140700178 creator A5016550578 @default.
• W2140700178 creator A5033443215 @default.
• W2140700178 creator A5033835226 @default.
• W2140700178 creator A5035435039 @default.
• W2140700178 creator A5042588749 @default.
• W2140700178 creator A5047228096 @default.
• W2140700178 creator A5056518843 @default.
• W2140700178 creator A5066282840 @default.
• W2140700178 creator A5068563937 @default.
• W2140700178 creator A5070901055 @default.
• W2140700178 creator A5072313172 @default.
• W2140700178 creator A5081417374 @default.
• W2140700178 creator A5083115147 @default.
• W2140700178 date "2015-02-01" @default.
• W2140700178 modified "2023-10-18" @default.
• W2140700178 title "Establishment and Characterization of Novel Human Primary and Metastatic Anaplastic Thyroid Cancer Cell Lines and Their Genomic Evolution Over a Year as a Primagraft" @default.
• W2140700178 cites W1675889352 @default.
• W2140700178 cites W1976577398 @default.
• W2140700178 cites W1977157996 @default.
• W2140700178 cites W1990004382 @default.
• W2140700178 cites W1993355130 @default.
• W2140700178 cites W1999740972 @default.
• W2140700178 cites W2001931464 @default.
• W2140700178 cites W2002063102 @default.
• W2140700178 cites W2007483903 @default.
• W2140700178 cites W2011351979 @default.
• W2140700178 cites W2023607197 @default.
• W2140700178 cites W2027855079 @default.
• W2140700178 cites W2055650944 @default.
• W2140700178 cites W2061655201 @default.
• W2140700178 cites W2070181423 @default.
• W2140700178 cites W2073622667 @default.
• W2140700178 cites W2073889874 @default.
• W2140700178 cites W2086511262 @default.
• W2140700178 cites W2093144236 @default.
• W2140700178 cites W2095067434 @default.
• W2140700178 cites W2099119979 @default.
• W2140700178 cites W2099998343 @default.
• W2140700178 cites W2109972881 @default.
• W2140700178 cites W2111520932 @default.
• W2140700178 cites W2113134419 @default.
• W2140700178 cites W2128496826 @default.
• W2140700178 cites W2130733741 @default.
• W2140700178 cites W2137190626 @default.
• W2140700178 cites W2147354890 @default.
• W2140700178 cites W2150575159 @default.
• W2140700178 cites W2152061559 @default.
• W2140700178 cites W2168261275 @default.
• W2140700178 cites W27451687 @default.
• W2140700178 cites W4256258598 @default.
• W2140700178 doi "https://doi.org/10.1210/jc.2014-2359" @default.
• W2140700178 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4318896" @default.
• W2140700178 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25365311" @default.
• W2140700178 hasPublicationYear "2015" @default.
• W2140700178 type Work @default.
• W2140700178 sameAs 2140700178 @default.
• W2140700178 citedByCount "20" @default.
• W2140700178 countsByYear W21407001782015 @default.
• W2140700178 countsByYear W21407001782016 @default.
• W2140700178 countsByYear W21407001782017 @default.
• W2140700178 countsByYear W21407001782018 @default.
• W2140700178 countsByYear W21407001782019 @default.
• W2140700178 countsByYear W21407001782020 @default.
• W2140700178 countsByYear W21407001782021 @default.
• W2140700178 countsByYear W21407001782022 @default.
• W2140700178 crossrefType "journal-article" @default.
• W2140700178 hasAuthorship W2140700178A5000444064 @default.
• W2140700178 hasAuthorship W2140700178A5007939153 @default.
• W2140700178 hasAuthorship W2140700178A5008473414 @default.
• W2140700178 hasAuthorship W2140700178A5015705148 @default.
• W2140700178 hasAuthorship W2140700178A5016350669 @default.
• W2140700178 hasAuthorship W2140700178A5016550578 @default.
• W2140700178 hasAuthorship W2140700178A5033443215 @default.
• W2140700178 hasAuthorship W2140700178A5033835226 @default.
• W2140700178 hasAuthorship W2140700178A5035435039 @default.
• W2140700178 hasAuthorship W2140700178A5042588749 @default.
• W2140700178 hasAuthorship W2140700178A5047228096 @default.
• W2140700178 hasAuthorship W2140700178A5056518843 @default.
• W2140700178 hasAuthorship W2140700178A5066282840 @default.
• W2140700178 hasAuthorship W2140700178A5068563937 @default.
• W2140700178 hasAuthorship W2140700178A5070901055 @default.
• W2140700178 hasAuthorship W2140700178A5072313172 @default.
• W2140700178 hasAuthorship W2140700178A5081417374 @default.
• W2140700178 hasAuthorship W2140700178A5083115147 @default.
• W2140700178 hasBestOaLocation W21407001781 @default.
• W2140700178 hasConcept C104317684 @default.
• W2140700178 hasConcept C10590036 @default.
• W2140700178 hasConcept C121608353 @default.
• W2140700178 hasConcept C16671776 @default.
• W2140700178 hasConcept C2779013556 @default.
• W2140700178 hasConcept C2779761222 @default.

• next